Utilization and outcomes of V-AV ECMO: A systematic review and meta-analysis.

Abhiraj SaxenaJohn CurranDanial AhmadNayeem NasherTakuma MiyamotoEugene BrailovskyMahek K ShahIndranee N RajapreyarJ Eduardo RameAntonino Loforte John W Entwistle Howard T Massey Vakhtang Tchantchaleishvili

Published in: Artificial organs (2023)

V-AV ECMO is a viable option for optimizing cardiopulmonary support in selected patients. Survival to weaning or bridging therapy appears comparable to more common ECMO configurations.

Keyphrases

extracorporeal membrane oxygenation
acute respiratory distress syndrome
end stage renal disease
mechanical ventilation
respiratory failure
chronic kidney disease
newly diagnosed
peritoneal dialysis
metabolic syndrome
adipose tissue
bone marrow
skeletal muscle
free survival
replacement therapy